Anuroop Packaging Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 11, 2025, 7:03 pm

Competitors of Anuroop Packaging Ltd

All Competitor Stocks of Anuroop Packaging Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:40 pm

Below is a detailed analysis of the quarterly data for Anuroop Packaging Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3.20 Cr.. The value appears to be declining and may need further review. It has decreased from 8.30 Cr. (Mar 2025) to 3.20 Cr., marking a decrease of 5.10 Cr..
• For Expenses, as of Jun 2025, the value is 2.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.60 Cr. (Mar 2025) to 2.34 Cr., marking a decrease of 2.26 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.86 Cr.. The value appears to be declining and may need further review. It has decreased from 3.70 Cr. (Mar 2025) to 0.86 Cr., marking a decrease of 2.84 Cr..
• For OPM %, as of Jun 2025, the value is 26.88%. The value appears to be declining and may need further review. It has decreased from 44.58% (Mar 2025) to 26.88%, marking a decrease of 17.70%.
• For Other Income, as of Jun 2025, the value is 0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.35 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.14 Cr..
• For Interest, as of Jun 2025, the value is 0.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.38 Cr. (Mar 2025) to 0.36 Cr., marking a decrease of 0.02 Cr..
• For Depreciation, as of Jun 2025, the value is 0.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.26 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.44 Cr.. The value appears to be declining and may need further review. It has decreased from 3.41 Cr. (Mar 2025) to 0.44 Cr., marking a decrease of 2.97 Cr..
• For Tax %, as of Jun 2025, the value is -63.64%. The value appears to be improving (decreasing) as expected. It has decreased from 26.69% (Mar 2025) to -63.64%, marking a decrease of 90.33%.
• For Net Profit, as of Jun 2025, the value is 0.72 Cr.. The value appears to be declining and may need further review. It has decreased from 2.50 Cr. (Mar 2025) to 0.72 Cr., marking a decrease of 1.78 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.65. The value appears to be declining and may need further review. It has decreased from 2.26 (Mar 2025) to 0.65, marking a decrease of 1.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 7:34 pm

Growth

Last Updated: September 5, 2025, 2:21 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Anuroop Packaging Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 5. It has decreased from 3.84 (Mar 24) to 3.65, marking a decrease of 0.19.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 5. It has decreased from 3.84 (Mar 24) to 3.65, marking a decrease of 0.19.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.63. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 4.63, marking an increase of 0.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.45. It has increased from 24.12 (Mar 24) to 29.45, marking an increase of 5.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.45. It has increased from 24.12 (Mar 24) to 29.45, marking an increase of 5.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.58. It has decreased from 26.12 (Mar 24) to 16.58, marking a decrease of 9.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 6.76 (Mar 24) to 7.59, marking an increase of 0.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.62. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 6.62, marking an increase of 0.63.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.20. This value is within the healthy range. It has increased from 4.77 (Mar 24) to 5.20, marking an increase of 0.43.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.66. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 3.66, marking a decrease of 0.17.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.63. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 3.63, marking a decrease of 0.20.
• For PBDIT Margin (%), as of Mar 25, the value is 45.77. This value is within the healthy range. It has increased from 25.87 (Mar 24) to 45.77, marking an increase of 19.90.
• For PBIT Margin (%), as of Mar 25, the value is 39.92. This value exceeds the healthy maximum of 20. It has increased from 22.94 (Mar 24) to 39.92, marking an increase of 16.98.
• For PBT Margin (%), as of Mar 25, the value is 31.33. This value is within the healthy range. It has increased from 18.26 (Mar 24) to 31.33, marking an increase of 13.07.
• For Net Profit Margin (%), as of Mar 25, the value is 22.06. This value exceeds the healthy maximum of 10. It has increased from 14.64 (Mar 24) to 22.06, marking an increase of 7.42.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 21.90. This value exceeds the healthy maximum of 20. It has increased from 14.64 (Mar 24) to 21.90, marking an increase of 7.26.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.33. This value is below the healthy minimum of 15. It has decreased from 15.85 (Mar 24) to 12.33, marking a decrease of 3.52.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 18.25 (Mar 24) to 17.81, marking a decrease of 0.44.
• For Return On Assets (%), as of Mar 25, the value is 7.81. This value is within the healthy range. It has decreased from 9.49 (Mar 24) to 7.81, marking a decrease of 1.68.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.34 (Mar 24) to 0.23, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.46, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has decreased from 0.67 (Mar 24) to 0.38, marking a decrease of 0.29.
• For Current Ratio (X), as of Mar 25, the value is 1.97. This value is within the healthy range. It has increased from 1.95 (Mar 24) to 1.97, marking an increase of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 1.73, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.80. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 7.80, marking an increase of 2.86.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.33. This value is within the healthy range. It has decreased from 5.53 (Mar 24) to 5.33, marking a decrease of 0.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.57. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 3.57, marking a decrease of 0.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 30.80. It has decreased from 34.34 (Mar 24) to 30.80, marking a decrease of 3.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.68, marking an increase of 0.45.
• For EV / EBITDA (X), as of Mar 25, the value is 3.67. This value is below the healthy minimum of 5. It has decreased from 4.76 (Mar 24) to 3.67, marking a decrease of 1.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.87, marking an increase of 0.15.
• For Price / BV (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.49, marking a decrease of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.87, marking an increase of 0.15.
• For EarningsYield, as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has increased from 0.20 (Mar 24) to 0.24, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness